Tower Research Capital LLC (TRC) - NPS PHARMACEUTICALS INC ownership

NPS PHARMACEUTICALS INC's ticker is P103PS and the CUSIP is 62936P103. A total of 205 filers reported holding NPS PHARMACEUTICALS INC in Q3 2014. The put-call ratio across all filers is 0.66 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of NPS PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2014$8,000
-90.5%
216
-93.3%
0.00%
-88.9%
Q3 2014$84,000
+2000.0%
3,240
+2317.9%
0.01%
+800.0%
Q1 2014$4,000
-97.9%
134
-97.8%
0.00%
-95.2%
Q3 2013$191,000
+324.4%
6,023
+102.0%
0.02%
+425.0%
Q2 2013$45,0002,9810.00%
Other shareholders
NPS PHARMACEUTICALS INC shareholders Q3 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 424,175$12,695,0005.06%
Opaleye Management Inc. 150,000$4,490,0003.32%
OAK RIDGE INVESTMENTS LLC 2,795,331$83,664,0002.10%
SCHOLTZ & COMPANY, LLC 60,350$1,806,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,408,729$42,163,0001.73%
First Light Asset Management, LLC 79,099$2,367,0001.68%
FCG ADVISORS, LLC 71,146$2,129,0001.51%
Rhenman & Partners Asset Management AB 166,970$4,997,0001.50%
BENDER ROBERT & ASSOCIATES 73,611$2,203,0001.48%
Eventide Asset Management 283,900$8,497,0001.32%
View complete list of NPS PHARMACEUTICALS INC shareholders